Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nanologica AB ( (SE:NICA) ) has issued an announcement.
Nanologica AB has acquired 100% of Ardena Södertälje AB, which will revert to its original name Syntagon AB, in an all-share deal valued at about SEK 8.6 million, adding a 45-employee contract development and manufacturing operation with sales of roughly SEK 80 million in 2025. The acquisition strengthens Nanologica’s production capacity, particularly in API development and manufacturing, is expected to be earnings-accretive in 2026, and offers estimated annual cost synergies of SEK 4–5 million through operational coordination, while a planned rights issue will both finance the transaction and set the subscription price for the seller’s new shares; Syntagon’s Nordic market position, modern facility, and an 18-month lock-up plus a 15‑month take‑or‑pay order commitment from the seller are intended to support profitable growth without additional capital injections into the subsidiary.
The most recent analyst rating on (SE:NICA) stock is a Hold with a SEK0.56 price target. To see the full list of analyst forecasts on Nanologica AB stock, see the SE:NICA Stock Forecast page.
More about Nanologica AB
Nanologica AB is a Sweden-based company focused on advanced materials and pharmaceutical-related production, including silica-based purification media. By integrating contract development and manufacturing capabilities, the company targets the pharmaceutical and life sciences markets, expanding its role in active pharmaceutical ingredient (API) production and related services.
Average Trading Volume: 168,597
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK53.01M
Learn more about NICA stock on TipRanks’ Stock Analysis page.